September 18, 2014 2:13 PM ET

Biotechnology

Company Overview of Agios Pharmaceuticals, Inc.

Key Executives for Agios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David P. Schenkein M.D.46 RelationshipsChief Executive Officer and Director57
Lewis Clayton Cantley Ph.D.90 RelationshipsCo-Founder, Director, Member of Scientific Advisory Board and Member of Nominating & Corporate Governance Committee65
Tak Wah Mak Ph.D., D.Sc.,FRSC187 RelationshipsCo-Founder and Member of Scientific Advisory Board68
Shin-San Su Ph.D.No RelationshipsCo-Founder and Senior Vice President of Research & Development58
Craig B. Thompson M.D.138 RelationshipsCo-Founder and Chairman of Scientific Advisory Board61
View More Key Executives

Agios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David P. Schenkein M.D. 46 RelationshipsAgios Pharmaceuticals, Inc.57
Lewis Clayton Cantley Ph.D. 90 RelationshipsAgios Pharmaceuticals, Inc.65
Tak Wah Mak Ph.D., D.Sc.,FRSC 187 RelationshipsAgios Pharmaceuticals, Inc.68
Craig B. Thompson M.D. 138 RelationshipsAgios Pharmaceuticals, Inc.61
Kevin P. Starr 76 RelationshipsThird Rock Ventures, LLC51
View All Board Members

Agios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Paul J. Clancy17 Relationships4 Executives
Compensation Committee Ph.D.Marc Tessier-Lavigne81 Relationships3 Executives
Nominating Committee Kevin P. Starr76 Relationships3 Executives
Corporate Governance Committee Kevin P. Starr76 Relationships3 Executives
Advisory Board M.D.Craig B. Thompson138 Relationships10 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$425.0K
425.0K
364.8K
Bonus
Not meaningful
Total Short Term Compensation$425.0K
425.0K
441.7K
Total Value of Options
21.6M
Compensation as of Fiscal Year
Agios Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Tully M. Friedman Resigns from Board of Directors of The Clorox Company, Effective November 19, 2014
September 17, 2014 12:30 PM ET
Colgate-Palmolive Company Announces Resignation of Nikesh Arora as Director
September 11, 2014 6:07 PM ET
Suominen Corporation Announces Appointments to its Nomination Board
September 02, 2014 6:30 AM ET
Energizer Holdings Inc. Announces Executive Leadership for Household Products and Personal Care Businesses
August 29, 2014 6:15 PM ET
ZIL Limited Announces Resignation of Munaf Ibrahim as Board of Director, Effective from August 25, 2014
August 27, 2014 10:53 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Agios Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.